Ariela Noy is a Hematologist in New York, New York. Dr. Noy is rated as an Elite provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Non-Hodgkin Lymphoma, Burkitt Lymphoma, Marginal Zone Lymphoma (MZL), Bone Marrow Transplant, and Tissue Biopsy.

Andrew Zelenetz is an Oncologist in New York, New York. Dr. Zelenetz is rated as an Elite provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Non-Hodgkin Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma (MCL), and Diffuse Large B-Cell Lymphoma (DLBCL).

Anita Kumar is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Kumar has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Kumar is currently accepting new patients.

Gilles Salles is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Salles is rated as an Elite provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Bone Marrow Transplant, and Splenectomy.

Michael Grossbard is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Grossbard is rated as a Distinguished provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Hodgkin Lymphoma, Primary Lymphoma of the Brain, Marginal Zone Lymphoma (MZL), Non-Hodgkin Lymphoma, and Bone Marrow Aspiration.

Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration.

Peihong Hsu is a Pathologist and an Oncologist in New Hyde Park, New York. Dr. Hsu has been practicing medicine for over 43 years and is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Leukocytosis, Sickle Cell Disease, Acute Myeloblastic Leukemia with Maturation, and Acute Myeloblastic Leukemia without Maturation.

Wayne Tam is a Pathologist and a Medical Genetics provider in New Hyde Park, New York. Dr. Tam is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Childhood Acute Myeloid Leukemia, Acute Promyelocytic Leukemia, Prolymphocytic Leukemia, and Chronic Myelogenous Leukemia (CML).

Joseph Glaser is a Radiologist in New Hyde Park, New York. Dr. Glaser is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Lung Nodules, Melorheostosis with Osteopoikilosis, Melorheostosis, and Osteopenia.

Francis Arena is a Hematologist and an Oncologist in New Hyde Park, New York. Dr. Arena is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Breast Cancer, and Paget Disease of the Breast.

Specializing in Internal Medicine and Cardio-Vascular Diseases. Full rang of non-invasive diagnostic testing available on-site. Pro active practice with emphasis on preventative care. Goal is to not just treat illness but to prevent adverse events. Dr. D'agostino is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are High Cholesterol, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Ectopic Heartbeat.

Miriam A. Knoll, MD, joined Northwell Health in 2024 as a radiation oncologist. She is also a clinical assistant professor of medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.After attending NYU Grossman School of Medicine, she completed a residency at the Icahn School of Medicine at Mount Sinai, before working at the John Theurer Cancer Center at Hackensack University Medical Center and Montefiore Nyack Hospital. She chose cancer care as a specialty in large part because she saw how collaborative that process needs to be for strong patient outcomes.I love working with a radiation oncology team, because that's truly what each patient needs, she says. Each of us contributes expertise and a different perspective, and that adds up to well-rounded care for each patient.At Northwell, Dr. Knoll's main focus is providing palliative radiation treatment. She communicates to patients how effective treatment can be for treating pain, and with far fewer side effects than many might expect. This type of therapy can really make a difference in helping people feel better, no matter where they are in their cancer journey.In addition to direct care, Dr. Knoll has worked to advance the field and to broaden patient knowledge and access by co-founding and serving at CEO of the Jewish Orthodox Women's Medical Association (JOWMA), as well as publishing articles in both academic journals and consumer publications such as JAMA Oncology, IJROBP, Advances in Radiation Oncology, Huffington Post and Forbes. She is an international speaker and writer focusing on medical care, the physician workforce, women in medicine, and social media in medicine. Dr. Knoll serves on national cancer committees at American Society of Clinical Oncology, American Society for Radiation Oncology, NRG Oncology, and the RTOG Foundation. She serves as a section editor for the journal Advances in Radiation Oncology.Over the course of her career, Dr. Knoll has learned from patients how valuable it is for those going through cancer to have a robust support system around them. That means family and friends and other patients, as well as a cancer care medical team.Ultimately, there are aspects of cancer that we can't control, although we step in and do as much as we can, she says. What we can control is offering as much support as possible so patients can draw on their own resilience for treatment. I see my role as being there for each patient on a personal level, while helping advance research and oncology care in a broader way. Dr. Knoll is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Breast Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Posterior Fossa Tumor.

Steven L. Allen, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in benign and malignant hematology, he is the System Head for Benign Hematology for the Northwell Health Cancer Institute. As an attending physician at the Monter Cancer Center, Dr. Allen focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Allen has been the principal investigator for numerous drug trials and has collaborated with several basic science labs, resulting in over 150 publications. Among his many professional affiliations, he is most active with the American Society of Hematology, having served in numerous leadership positions and committees. In addition, he is a dedicated member of the American Society of Clinical Oncology, Empire State Hematology and Oncology Society, and the American College of Physicians. Dr. Allen earned his medical degree from the Johns Hopkins School of Medicine. He trained in internal medicine and hematology/oncology at New York Hospital-Weill Cornell Medical Center. Dr. Allen is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Leukemia, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration.

Douglas Gladstone is a Transplant Surgeon in Lake Success, New York. Dr. Gladstone is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Hodgkin Lymphoma, and Bone Marrow Aspiration.

Erin Jou, MD is an attending physician at the Monter Cancer Center. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Jou is an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Jou s practice is solely dedicated to the treatment of patients with benign and malignant hematologic disorders where she focusses on providing compassionate, personalized, evidence-based multi-disciplinary care. She is involved in clinical research at Monter Cancer Center and actively enrolls patients in clinical trials. After graduating from the Pennsylvania State University, Dr. Jou earned her medical degree from Jefferson Medical College. She trained in Internal Medical and Hematology/Oncology at Montefiore Medical Center. Dr. Jou is an active member of the American Society of Hematology. Dr. Jou is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration.

Shams Shakil, MD, PhD, MS, is an attending physician based at the Monter Cancer Center where he specializes in the treatment of patients with benign and malignant hematologic conditions. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Shakil is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Shakil maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. He earned his medical degree from Chittagong Medical College in Bangladesh, his PhD from Hiroshima University School of Medicine and his MS in Medical Informatics from the Oregon Health and Science University. His fellowship in Hematology/Oncology was completed at Brookdale University Hospital Center. Dr. Shakil has a research background in both surgical oncology and radiation oncology. He is an active member of the American Society of Hematology. Dr. Shakil is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Sickle Cell Disease, Anemia, Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration.

Anna Levy DO, is Medical Director of Hepatobiliary Malignancies and the Hepatic Artery Pump Infusion Program, based at the Monter Cancer Center. Board certified in Internal Medicine, Hematology, and Medical Oncology, she is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Levy s scope of clinical practice includes liver, bile duct, esophageal, gastric, colon, rectal, and anal malignancies. She focuses on providing compassionate, personalized, and evidence based multidisciplinary care. Dr. Levy earned her medical degree at the Lake Erie College of Osteopathic Medicine. She trained in Internal Medicine at the Christiana Care Health System and completed her fellowship in Medical Oncology and Hematology at Long Island Jewish Medical Center. An active member of the American Society of Clinical Oncology, she is fluent in Russian. Dr. Levy is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Familial Colorectal Cancer, Familial Pancreatic Cancer, Anal Cancer, Colorectal Cancer, and Bone Marrow Aspiration.

Suzanne Ludlum is a Nurse Practitioner in Lake Success, New York. Ms. Ludlum is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Classical Hodgkin Lymphoma, Marginal Zone Lymphoma (MZL), Small Lymphocytic Lymphoma (SLL), and Smoldering Multiple Myeloma.

Craig Devoe, MD, MHCM, is Chief of the Don Monti Division of Medical Oncology and Hematology and Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Medical Oncology, Dr. Devoe specializes in gastrointestinal malignancies (colorectal cancer, pancreatic cancer), and cutaneous malignancies (malignant melanoma) at the Monter Cancer Center where he maintains an active practice focused on providing compassionate, personalized, evidence-based multi-disciplinary care. In addition, Dr. Devoe is a research investigator through the Northwell Health Cancer Institute s NCORP (NCI Community Oncology Research Program) grant and industry-sponsored trials. He works closely with the Cancer Institute s clinical trials office in terms of medical oversight of processes and operations, having completed a training program in clinical research design through the Harvard School of Public Health. Dr. Devoe has served as a member of the Alliance Audit Committee performing oversight at other nationally based cancer programs. After earning his medical degree from the State University of New York (SUNY) at Stony Brook School of Medicine, Dr. Devoe trained in internal medicine at NYU Langone Long Island and completed his fellowship in Hematology/Oncology at SUNY Stony Brook. Dr. Devoe furthered his leadership and managerial skills by earning a master s in Health Care Management degree from the Harvard School of Public Health. Dr. Devoe is an active member of the American Medical Association and the American Society of Clinical Oncology. Dr. Devoe is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Tissue Biopsy.

Deborah Gruber is a Neurologist in Lake Success, New York. Dr. Gruber is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Glioblastoma, Glioma, Astrocytoma, and Gliomatosis Cerebri.